Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
WuXi XDC granted Ona Therapeutics an exclusive global license to its WuXiTecan-2 payload, including an upfront, milestone payments, and tiered royalties, plus CMC development and manufacturing support.
WuXi XDC said it has out-licensed its WuXiTecan-2 payload-linker technology platform to Ona Therapeutics to support novel ADC research and development.